Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"Prognostic Role of Portal Hypertension Assessed by Non-invasive Methods to Stratify Surgical Risk in Compensated Advanced Chronic Liver Disease Patients Undergoing Elective Extrahepatic Surgery: ELASTOSURGERY STUDY."

NCT04615091 is registered in ClinicalTrials.gov with Azienda Ospedaliera Universitaria Integrata Verona as lead sponsor.

NCT NCT04615091
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04615091 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"Prognostic Role of Portal Hypertension Assessed by Non-invasive Methods to Stratify Surgical Risk in Compensated Advanced Chronic Liver Disease Patients Undergoing Elective Extrahepatic Surgery: ELASTOSURGERY STUDY."
Lead sponsor
Azienda Ospedaliera Universitaria Integrata Verona
Phase
Observational
Overall status
Unknown status
Start date
August 30, 2020
Completion date
August 31, 2022
Enrollment
250 (estimated)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

advanced chronic liver disease, surgery--complications